Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

IMRA America Inc.

Jan 2012
IMRA America Inc. of Ann Arbor, Mich., and MagArray Inc. of Sunnyvale, Calif., will collaborate to develop MagArray’s magneto-nanoparticle immunoassay technology, which is based on research from Stanford University in California. The companies will develop highly sensitive immunoassay sensor systems. If the work progresses as planned, IMRA will support MagArray’s development with funding of up to $10 million over the next three and a half years. IMRA also will provide scientific and technical support, including nanomaterial technologies. MagArray’s technology could play a leading role in the way that cancer and other serious diseases are diagnosed and treated, said Takashi Omitsu, IMRA’s president.

AmericasBiophotonicsBusinessfiber laser researchfiber opticsimagingimmunoassay sensor systemsImra Americalaser-made nanoparticlesMagArrayMagArray magneto-nanoparticle immunoassay technologynanonanomaterials technologyRapidScanSensors & DetectorsStanford UniversityTakashi Omitsulasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.